NanoDimension Capital
Carl Pabo is the Founder and Research Director of Protean Futures LLC, established in 2007, where innovative strategies for addressing complex technical and social challenges are developed. Additionally, Carl Pabo serves as a Scientific Advisor at NanoDimension and previously held the roles of Founder and President at Humanity 2050, where focus was placed on tackling global issues such as climate change and artificial intelligence risks. Academic credentials include visiting professorships at institutions such as California Institute of Technology, Harvard Medical School, and Stanford University, as well as a tenure as Professor at the Massachusetts Institute of Technology. Carl Pabo holds a Ph.D. in Biochemistry and Molecular Biology from Harvard University and a B.S. in Molecular Biophysics and Biochemistry from Yale University.
This person is not in any teams
NanoDimension Capital
NanoDimension is a venture capital firm committed to building companies developing market disruptive technologies on the nano-scale. Founded in 2002, and with offices in Europe and the United States, NanoDimension focuses on early to mid stage investments across business sectors.